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strong prejudice against the use of immunosup-
pressive drugs in SLE, particularly lupus nephritis 
and cerebritis. It is true that the benefit of a 
comprehensive and conservative regimen for all 
aspects of SLE is frequently overlooked; however, 
few rheumatologists and nephrologists would be 
satisfied to treat active lupus nephrit is with bed 
rest and salicylates alone. The defense of 
immunosuppressive therapy for the life-threaten-
ing complications of SLE is not the business of this 
brief review; however, many knowledgeable physi-
cians use this type of therapy. even though its 
benefit has not been conclusively confirmed by 
controlled, prospective, double-blind studies. 
This book does belong in the library of anyone 
seriously interested in the care of SLE patients as a 
supplement of the standard modem texts on the 
subject. 
James N. Gillian, M.D. 
Dallas. Texas 
Zola Cooper Memorial Clinicopathologic Semi~ 
nar- 1974. Eli Lilly and Company Educa-
Vol. 68, No. I 
tional Resources Program, Indianapolis, 
1974. 
Many speculations and different personal 
experiences are presented in this series of slides but 
t hey do not all seem to be scientifically accurate. 
Most of the material included is up to date; 
however a discussion of T and B cells is not 
included in the section on Sezary syndrome. Also, 
in t he discussion of amyloidosis there is nothing 
ment ioned about t he diagnostic electron micro-
scopic appearance of the amyloid fibrils. Most 
photomicrographs are good, especially the high-
power views; some of the low-power pictures could 
be improved. 
This seminar is best suited for someone who has 
had at least two years of clinicopathologic training 
in dermatology, such as third-year dermatology 
residents, dermatopathology fellows, or pathology 
residents. 
Ana M. Eng, M.D. 
Chicago, Illinois 
